Lisdexamfetamine, marketed as Vyvanse, is a scheduled medication indicated for hyperactivity and attention difficulties in youngsters and individuals. In Canada, its distribution is managed by Health Canada. This overview seeks to present clear information on its therapeutic applications , advers… Read More